Beatrice Hahn, elected to the National Academy of Sciences in 2012, has a longstanding interest in the origins and evolution of human pathogens. She is recognized for deciphering the primate origins of human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2) and the malaria parasite Plasmodium falciparum. Hahn has also developed noninvasive methods to study the zoonotic potential of microbes that infect endangered primate species in the wild. At present, Hahn is focused on developing a protective human AIDS vaccine by dissecting the HIV-1 transmission process and studying the biological properties of newly transmitted founder viruses.
Over the years, Hahn has earned numerous honors, from receiving a National Institutes of Health R37 Merit Award in 2008 to election to both the American Academy of Microbiology and the Institute of Medicine of the National Academies. In 2002, Discover magazine named her one of "The 50 Most Important Women in Science." Hahn credits "a lot of luck, good health, a talented team, and a good husband" for her success. Together with her husband George Shaw, another international leader in human and simian immunodeficiency virus (SIV) research, Hahn continues to make impressive contributions to this field of medical science. Both Hahn and Shaw are now based at the University of Pennsylvania's Perelman School of Medicine.
Early Introduction to Medicine
Born in Munich, Germany, Hahn was introduced to medical science by her father, who worked as a primary care physician in rural Bavaria. Her father was among the first doctors in the region to use an X-ray machine for diagnostics. "Watching him taught me what it means to be a physician," says Hahn. As an adolescent, Hahn "liked to draw blood and look at urine slides under the microscope. He let me do that," she adds. She further enjoyed discussing cases with him at the dinner table.
In school, Hahn was curious to learn about biology. Her original education goals, however, were directed toward becoming a physician. She left her home to attend the Technical University of Munich Medical School, where she earned her doctorate in medicine in 1982.
Hahn's doctoral thesis (1) foreshadowed her later work but revealed some of her past influences. As a grade school student she enjoyed herding and milking cows. Rural Bavaria, where cows are a ubiquitous part of the landscape, also helped to shape her thinking. Hahn wondered how bovine illnesses might affect humans, given the closeness of human interaction with cattle. The bovine leukemia virus, the subject of her thesis, is closely related to HTLV-1, a human tumor virus.
Robert Gallo and the Discovery of HIV-1
While at the Technical University of Munich, a colleague introduced Hahn to virologist Robert Gallo, then a researcher at the National Cancer Institute in Bethesda, MD. Gallo's sister had died at an early age from leukemia, a disease to which he dedicated much of his early research. Gallo was particularly interested in tumor-causing retroviruses, which are single-stranded RNA viruses that insert DNA copies of their genome into their host cell to replicate. Bovine leukemia virus is one example of such a retrovirus.
Hahn wished to work in Gallo's laboratory, but Gallo could not offer her financial support. Hahn successfully applied for a fellowship from the German Science Foundation. On May 1, 1982, she arrived at the National Cancer Institute. "At the time," she recalls, "doing basic biomedical research in Germany was not an attractive option." Such opportunities then were far better in the United States. science have since greatly improved in Germany," she says, but she had decided to remain in the United States.
The year before her arrival, clinical cases of the disease now known as AIDS surfaced in the United States. The initial cases were reported among gay men with no known cause of impaired immunity, and yet these individuals often showed symptoms of a rare form of pneumonia and skin cancer. A Centers for Disease Control and Prevention Task Force was formed to monitor the outbreak.
Gallo's laboratory, of which Hahn was now a part, investigated the cause. George Shaw arrived at Gallo's laboratory in 1983, and Hahn and Shaw's first collaboration began. A colleague of the couple, Mikulas Popovic, succeeded in culturing and isolating the virus. Hahn and Shaw then cloned its genome. In 1984, Gallo and his collaborators published a series of four papers (2) (3) (4) (5) in the journal Science demonstrating that the isolated retrovirus was the cause of AIDS. A French team led by virologist Luc Montagnier, who was then at the Pasteur Institute, also isolated the retrovirus from a patient (6); Gallo is thus regarded as the codiscoverer of HIV-1.
AIDS as a Zoonosis
In 1985, Hahn and Shaw were recruited to initiate human retrovirus research efforts at the University of Alabama at Birmingham's Comprehensive Cancer Center. With perseverance, they both rose up the ranks at the university. Over time, Hahn became a tenured professor in the Departments of Medicine and Microbiology and then served as the codirector of the Center for AIDS Research. Hahn and Shaw have always enjoyed "good chemistry," as she says, both in and out of the laboratory, and they married in 1988.
A summary of the pair's studies on the origin of AIDS was published in Science in January 2000 (7) . As for nearly all of Hahn and Shaw's work, the report foreshadowed their later investigations. "Humans are not the natural hosts of either HIV-1 or HIV-2," the team wrote. "Instead, these viruses have entered the human population as a result of zoonotic, or cross-species, transmission. We now know of at least 18 distinct primate lentiviruses that naturally infect different African primates." Lentiviruses are members of a family of retroviruses characterized by a long incubation period. The researchers noted that two such simian immunodeficiency viruses, SIVcpz from chimpanzees and SIVsmm from sooty mangabeys, "are the cause of acquired immunodeficiency syndrome in humans. Together, they have been transmitted to humans on at least seven occasions."
As for how these transmissions occurred, Hahn and her team wrote that among wildliving primates, "biting and predation represent the most likely means of cross-species infection." Hunting bushmeat "provides a plausible explanation for the transmission of lentiviruses to humans." The hypothesis drew attention to the bushmeat trade and related factors, such as the effects of commercial logging and the link between socioeconomic factors and disease. Now, the challenge was to directly study SIVcpz in wild chimpanzees using ethical means. Hahn says, "Primates, and in particular apes, are dear to my heart."
Novel Research Tool
Hahn credits two of her former students, Mario Santiago and Brandon Keele, with establishing then-novel noninvasive methods that allowed the team to diagnose and molecularly characterize SIV infections in wildliving chimpanzees, gorillas, sooty mangabeys, and other primates. Santiago established methods to amplify SIVcpz nucleic acids from fecal RNA, and Keele began working with RNAlater, a solution used to preserve fecal samples. Keele subsequently developed a highly sensitive fecal-based antibody assay. Collaborating primatologists would describe themselves as being "glorified pooper scoopers," but the effort was simple and ingenious. The noninvasive diagnostic methods yielded critical information without harming the endangered species.
Around this time, Hahn published a paper in Science (8), of which the noted primatologist Jane Goodall was a coauthor. "Our work in Gombe with Jane Goodall was very instrumental because Gombe is the only place in the world where SIVcpz-infected wild chimpanzees tolerate the presence of human observers," Hahn says. Of an initial 58 wild chimpanzees tested, one healthy 23-y-old sexually active male from Gombe National Park, Tanzania nucleic acids in fecal samples collected from the forest floor. They further developed genotyping approaches to amplify host mitochondrial and genomic markers from these same specimens for species, sex, and individual identification. The researchers used these approaches to conduct the first molecular epidemiological field study of SIVcpz in wild-living nonhabituated chimpanzees in west central Africa. The study garnered widespread attention, putting Hahn's work in the spotlight.
Three years later, yet another paper (10) surprised both the public and the scientific community. Hahn and an international consortium under her leadership found that wild chimpanzees naturally infected with SIVcpz, long believed to be harmless to nonhuman primates, could contract a potentially fatal AIDS-like syndrome. Hahn and her team arrived at the conclusion by studying fecal samples collected at Gombe National Park, where chimpanzee biology and behavior are closely monitored. SIVcpzinfected chimpanzees turned out to be 10-to 16-times more likely to die than uninfected chimpanzees. Similarly, infected female chimpanzees were less likely to give birth, and infants born to infected mothers were less likely to survive. The researchers learned that the virus was transmitted sexually and through mother's milk. Over the nine-year study period, up to 20% of 94 chimpanzees were infected at any one time. The study, which has influenced both chimpanzee health management and subsequent human HIV research, involved the first postmortem examination of a chimpanzee that had died from AIDS.
Origin of the Deadliest Human Malaria Parasite
Hahn and colleagues next turned their attention to the evolutionary origin of the human malaria parasite, Plasmodium falciparum, which causes several hundred million cases of clinical malaria and more than one million deaths every year. Using the same noninvasive techniques that had uncovered the origins of AIDS, Hahn, Shaw, and their colleagues traced this deadly form of human malaria to West African gorillas (11) .
Hahn had previously read about P. falciparum DNA sequences found in ape fecal samples, which led to a light-bulb moment. "We knew we were in business because we had a freezer full of such samples!" she says. The study, published in 2010, involved nearly 3,000 chimpanzee, gorilla, and bonobo fecal samples (11) . The findings now inform malaria eradication efforts and provide insights into whether ape Plasmodium infections cross over to humans.
Recent and Ongoing Projects
Hahn and her colleagues continue to study ape Plasmodium infections, and are investigating whether African apes represent a recurrent source of human infection. The researchers also continue to monitor SIVcpz infection of wild chimpanzees, focusing on Gombe National Park and other sites in Tanzania.
Studies of HIV-1 transmission are also ongoing. Hahn's Inaugural Article, entitled "Phenotypic Properties of Transmitted Founder HIV-1," concerns the characterization of these transmitted founder (TF) viruses (12) . Founder viruses, which first establish HIV infection in an individual, help to define the traits that are necessary for successful viral replication within a new host. Hahn and her group found that TF viral particles are 1.7-fold more infectious and contain 1.9-fold more viral envelope protein per particle compared with chronic control viruses. The team further determined that TF viruses exhibit improved interaction with dendritic cells that are key immune regulatory cells within the mucosa. TF viruses also exhibit relative resistance to a potent immune defense protein known as IFN-α. "These viral properties, which likely act in concert, should be considered in the development and testing of AIDS vaccines," she says.
Hahn and Shaw are involved in a multiinstitutional project to guide the development of a preventative human AIDS vaccine: the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, headed by physician and immunologist Barton Haynes at Duke University. Hahn believes that a protective vaccine is not at arm's length, but it is on the horizon and represents a realistic goal. She mentions that available antiretroviral drugs keep the virus at bay, but not everyone can afford or tolerate them. Helping to make an AIDS vaccine remains a high priority for her team.
Hahn emphatically summarizes immediate goals and aspirations in just two words: "staying funded!"
